Position
Chief Financial Officer
Company
Eton Pharmaceuticals
Deer ParkBiotechnologyHealthcareHealth CarePharmaceuticalDescription
On April 16, 2026, Eton Pharmaceuticals announced the appointment of Judith Matthews as Executive Vice President, Accounting and Finance. She will take on the role of Chief Financial Officer starting June 1, 2026, succeeding James Gruber. Gruber will continue in his position until May 31, 2026, before transitioning to a consulting role
Quick answer
Eton Pharmaceuticals Appoints Judith Matthews as Executive Vice President (April 16, 2026). Eton Pharmaceuticals is based in Deer Park, Illinois, United States.
- What did Eton Pharmaceuticals announce on April 16, 2026?
- On April 16, 2026, Eton Pharmaceuticals announced the appointment of Judith Matthews as Executive Vice President, Accounting and Finance. She will take on the role of Chief Financial Officer starting June 1, 2026, succeeding James Gruber.
- What does Eton Pharmaceuticals do?
- Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.
- Where is Eton Pharmaceuticals based?
- Eton Pharmaceuticals is based in Deer Park, Illinois, United States.
- Which similar companies made leadership changes around the same time?
- Pelthos Therapeutics (April 10, 2026), Recursion Pharmaceuticals (March 25, 2026), Aquestive Therapeutics, Inc. (March 20, 2026) and MBX Biosciences, Inc. (March 10, 2026) also announced leadership changes within 45 days of Eton Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pelthos Therapeutics Appoints John M. Gay as Chief Financial Officer (April 10, 2026)
- Recursion Pharmaceuticals Appoints Vicki Goodman, M.D., as Chief Medical Officer (March 25, 2026)
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
- Juvisé Pharmaceuticals Appoints Renaud Sermondade as CEO (April 16, 2026)
Who to call at Eton Pharmaceuticals, and when
A new leader at Eton Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Eton Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eton Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eton Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eton Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Eton Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.